Kenneth Meehan, MD

Trials

Studies that name Kenneth Meehan, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:47 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT03480360 · Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

  Dartmouth-Hitchcock Medical Center · completed · Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia · principal investigator
• Ph1
  NCT02916979 · Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG

  Dartmouth-Hitchcock Medical Center · completed · Leukemia, Lymphoid, Leukemia, Myeloid, Myelodysplastic Syndromes · principal investigator
• Ph2
  NCT02139280 · Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy

  Dartmouth-Hitchcock Medical Center · completed · Hematologic Malignancies · principal investigator
• N/A
  NCT01382615 · Protocol to Obtain Blood and Bone Marrow Samples for Myeloma Research

  Dartmouth-Hitchcock Medical Center · terminated · Multiple Myeloma · principal investigator
• Ph2
  NCT00439465 · Adoptive Cellular Immunotherapy Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma

  Dartmouth-Hitchcock Medical Center · completed · Myeloma, Transplant-eligible Patients · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.